Sign inJoin waitlistJoin the waitlist

Jennifer Eads

Chair · University of Pennsylvania Health System

Credentials: · · · ·

History

University of Pennsylvania Health System
Present
GI Clinical Research · University of Pennsylvania Health System
Present
National Clinical Trials Network · University of Pennsylvania Health System
Present

Case Western Reserve University/University Hospitals Cleveland Medical Center
2012–2014
Boston Children's Hospital
2011–2012
Internal Medicine
Case Western Reserve University/University Hospitals Cleveland Medical Center
2008–2011
Pediatrics
Boston Children's Hospital
2005–2008
Tufts University School of Medicine
2001–2005

Research

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Journal of Clinical Oncology · 2016 · 305 citations
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
Journal of the National Comprehensive Cancer Network · 2018 · 284 citations
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Pancreas · 2020 · 159 citations

NM
Neal Meropol
7 papers
Daniel Pryma
6 papers
David Metz
6 papers
Bryson Katona
5 papers
HL
Hwan Lee
5 papers · 5 as a resident
Jennifer Chan
4 papers
Michael Soulen
4 papers
Thomas Karasic
4 papers
Thor Halfdanarson
4 papers
Al Benson
3 papers
Alok Khorana
3 papers
Charles Schneider
3 papers

Grants

Abramson Cancer Center Lead Academic Participating Sites (LAPS)
National Cancer Institute · UG1
Contact PI · $543.7K · University of Pennsylvania
2026–2032

Clinical trials

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Principal investigator · Recruiting · Phase 1, Phase 2
Chimeric Therapeutics
2024–2027
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
Principal investigator · Suspended · Phase 2, Phase 3
National Cancer Institute (NCI)
2019–2026
Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
Principal investigator · Withdrawn · Phase 1, Phase 2
Case Comprehensive Cancer Center
2018–2021
Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer
Principal investigator · Terminated · Phase 2
Case Comprehensive Cancer Center
2016–2018